We are thrilled to announce that we have made our debut at Medlab Middle East 2024 in Dubai. Presenting our innovative solutions for traceability, transportation, and pre-analytics marks a significant milestone for us. We aim to showcase how our proposals can revolutionize the way medical samples are being handled and processed, enhancing the efficiency and…
Esamed will propose two new preanalytical solutions made by the END-MED company, such as the management of capping and uncapping of urine and blood test tubes: – Decapper –> DC 2000 SR – Recapper –> RC 2000 SR DC 2000 SL – TUBE DECAPPER https://www.youtube.com/watch?v=_jwx3RP_aFM RC 2000 SL – TUBE RECAPPER https://www.youtube.com/watch?v=slfGfGmT3q8
Esamed is pleased to present Eugenio, a new instrument capable of reading the barcodes of test tubes between one or three different racks. The project, entirely carried out by Esamed, aims to integrate with EsaTrace and LIS, in order to trace every single detail of each transport. For more information click here.
It is a pleasure to inform you that we will be present at Medica with new interesting products. You will find us at Stand 1E58 Hall 01.
We inform you that we have new tests for monkeypox available soon. Image source: Corriere del Veneto
With great pleasure we inform you that Esamed will be present at the Scivac International Congress with its stand. The conference will take place at the Rimini Palacongressi from 27 to 29 May.
Esamed provides several solutions to diagnose Covid-19, in detail: -Test of the first generation: Lepu, Genrui -Second generation test: Flurolit -Third generation test: Frend -Molecular biology test: CPA
Esamed is proud to announce that we have been selected by Emergency to cover requests for clinical chemistry POCT exams worldwide by supplying our systems.
CPA EASYNAT® REAL-TIME MOLECULAR DIAGNOSTIC SYSTEM Click here for more information about the new molecular biology instrument.
The new test for the Nanoentek Frend System is available! It is a point-of-care testing (POCT) which can be used to check whether patients have developed immune responses to SARS-CoV-2 using human serum or plasma. Features: -3 minutes, fast result -2 steps, easy to use -97% and 96%, positive and negative percent agreement -microfluidic qualitative…
FREND SYSTEM – NANOENTEK Click here for further informations about the new instrument of immunometry for Covid-19 third generation tests.
